Filing Details
- Accession Number:
- 0001209191-23-004005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-19 16:07:54
- Reporting Period:
- 2023-01-17
- Accepted Time:
- 2023-01-19 16:07:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-17 | 4,000 | $72.14 | 5,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-17 | 4,000 | $312.03 | 1,875 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-18 | 442 | $72.14 | 2,317 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-18 | 442 | $312.17 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-01-17 | 4,000 | $0.00 | 4,000 | $72.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-01-18 | 442 | $0.00 | 442 | $72.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,000 | 2024-05-31 | No | 4 | M | Direct | |
| 15,558 | 2024-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $312.03 (range $312.00 to $312.14).
- Open market sales reported on this line occurred at a weighted average price of $312.17 (range $312.00 to $312.53).
- Fully vested.
Billionaire Hedge Funds
